APOLLON: A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC).
2018
3523Background: APOLLON is an open-label, single-arm phase I/II study investigating the efficacy and safety of
panitumumab(Pmab) in combination with TAS-102 (
trifluridine/
tipiracil) in pts with RA...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
3
Citations
NaN
KQI